In vitro and in vivo studies have established gallium nitrate as an ef
fective chemotherapeutic agent against human medulloblastoma. In vitro
, gallium nitrate reduced cell proliferation and DNA synthesis of medu
lloblastoma Daoy. Gallium inhibits the availability of Fe-59 to ribonu
cleotide reductase and has a direct effect on the enzyme itself. In vi
vo, gallium demonstrated similar effects on the medulloblastoma Daoy c
ell line in nude mice. Tumor growth rate and actual size were decrease
d; however, severe nephrotoxicity and mortality were observed. In our
study, intradermal injections of medulloblastoma Daoy cells were given
to nude mice and then tumors were allowed to grow. Tumor-bearing mice
received a 15-day gallium (50 mg/kg/day) regimen, 20-day rest, 7-day
gallium (66.5 mg/kg/day) dose escalation regimen beginning when tumor
size exceeded 8-10 mm in diameter. All treated and control mice receiv
ed saline hyperhydration during both treatment sessions. Our study res
ulted in the prevention of severe toxicity and an inhibition of tumor
growth. No toxicity occurred with gallium nitrate at 50 mg/kg/day. Sev
ere morbidity and mortality were observed at the higher gallium dose l
evel (66.5 mg/kg/day), suggesting that the 50 mg/kg/day dose is the ap
propriate level when investigating gallium nitrate as a chemotherapeut
ic agent in nude mice.